Back |
home / stock / catb / catb message board
Subject | By | Source | When |
---|---|---|---|
News: $CATB Catabasis Pharmaceuticals to Present at Upcoming | whytestocks | investorshub | 06/18/2019 6:20:47 PM |
= $CATB = Moved to BUY on Swing | LiveLife | investorshub | 11/29/2018 1:53:19 AM |
Perfect buy-in @0,60 as it seems - nice | Klinsmann | investorshub | 11/28/2018 5:50:26 PM |
Good news, time to buy right now! | Klinsmann | investorshub | 11/28/2018 6:17:38 AM |
Still on watch - its settling during the | Klinsmann | investorshub | 11/22/2018 6:17:24 PM |
Great day so far - looks like 1$ | Klinsmann | investorshub | 09/19/2018 1:50:40 PM |
Potential for P3 trial and company overall. | Pentium | investorshub | 09/03/2018 6:31:51 PM |
What, you here again, we must be using | janeyH | investorshub | 08/30/2018 5:20:01 PM |
$CATB ~ Amazing it broke prior .75 resistance. | THREE-DAY-TRADER | investorshub | 08/29/2018 8:07:51 PM |
$CATB = New Recent high of .75!! | THREE-DAY-TRADER | investorshub | 08/24/2018 6:27:02 PM |
$CATB ~ Nice progressive movement since Monday (8/20). | THREE-DAY-TRADER | investorshub | 08/23/2018 7:45:31 PM |
$CATB ~ Holding above .61+ support after multiple | THREE-DAY-TRADER | investorshub | 08/22/2018 7:54:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Catabasis Pharmaceuticals Inc. Company Name:
CATB Stock Symbol:
NASDAQ Market:
Catabasis Pharmaceuticals Inc. Website:
-- Astria Reflects Company’s Patient-Focused Mission -- -- Promising Lead Program STAR-0215 is in Preclinical Development to Prevent Attacks in Hereditary Angioedema -- -- Company to Begin Trading Under New Ticker Symbol ATXS on September 9 -- Cataba...
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update. “We are focused on advancing the development of our lead program, QLS-215, as a differe...